Early response to benralizumab in severe, eosinophilic asthma: a real-world study in Switzerland

被引：0

作者：

Schuoler, Claudio ^{[1
]}

Van Iperen, Peter ^{[1
]}

Stolz, Daiana ^{[2
]}

Charbonnier, Florian ^{[3
]}

Bridevaux, Pierre-Olivier ^{[4
]}

Jandus, Peter ^{[3
]}

Fiechter, Rene ^{[5
]}

Leuppi, Jorg D. ^{[6
]}

Hauser, Thomas ^{[7
]}

Pavlov, Nikolay ^{[8
]}

Scherer, Thomas ^{[9
]}

Huber, Michael ^{[10
]}

Azzola, Andrea ^{[11
]}

Piecyk, Andreas ^{[12
]}

Rothe, Thomas ^{[13
]}

机构：

[1] AstraZeneca, Baar, Switzerland

[2] Univ Hosp Basel, Basel, Switzerland

[3] Univ Hosp Geneva HUG, Geneva, Switzerland

[4] Ctr Hosp Valais Romand, Sion, Switzerland

[5] Pulm Specialty Ctr Fiechter, Aathal, Switzerland

[6] Cantonal Hosp Baselland, Liestal, Switzerland

[7] Immunol Ctr Zurich, Zurich, Switzerland

[8] Bern Univ Hosp, Bern, Switzerland

[9] Pulm Clin Bethanien, Zurich, Switzerland

[10] Hosp Wetzikon GZO, Wetzikon, Switzerland

[11] Cantonal Hosp Luzern, Luzern, Switzerland

[12] Pulm Ctr Hirslanden, Zurich, Switzerland

[13] Cantonal Hosp Graubunden, Chur, Switzerland

来源：

关键词：

Treatments; Quality of life; Severe asthma;

D O I：

10.1183/13993003.congress-2023.PA1903

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

引用

页数：3